Global CAR T-Cell Immunotherapy Market Insights, Forecast to 2028

  • Report ID:236872
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 119
                              
CAR T-Cell Immunotherapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Monotherapy Combination Therapy Segment by Application Hematologic Malignancies Solid Malignancies By Company AbbVie Celgene Kite Pharma Oxford BioMedica Novartis Gilead Pfizer Cellectis Bellicum Mustang Bio CARsgen Therapeutics Xyphos Minerva Biotechnologies Adaptimmune Ziopharm Oncology Aurora Biopharma Creative Biolabs By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Monotherapy 1.2.3 Combination Therapy 1.3 Market by Application 1.3.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hematologic Malignancies 1.3.3 Solid Malignancies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global CAR T-Cell Immunotherapy Market Perspective (2017-2028) 2.2 CAR T-Cell Immunotherapy Growth Trends by Region 2.2.1 CAR T-Cell Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 CAR T-Cell Immunotherapy Historic Market Size by Region (2017-2022) 2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028) 2.3 CAR T-Cell Immunotherapy Market Dynamics 2.3.1 CAR T-Cell Immunotherapy Industry Trends 2.3.2 CAR T-Cell Immunotherapy Market Drivers 2.3.3 CAR T-Cell Immunotherapy Market Challenges 2.3.4 CAR T-Cell Immunotherapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top CAR T-Cell Immunotherapy Players by Revenue 3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2017-2022) 3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2017-2022) 3.2 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue 3.4 Global CAR T-Cell Immunotherapy Market Concentration Ratio 3.4.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2021 3.5 CAR T-Cell Immunotherapy Key Players Head office and Area Served 3.6 Key Players CAR T-Cell Immunotherapy Product Solution and Service 3.7 Date of Enter into CAR T-Cell Immunotherapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 CAR T-Cell Immunotherapy Breakdown Data by Type 4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2017-2022) 4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028) 5 CAR T-Cell Immunotherapy Breakdown Data by Application 5.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2017-2022) 5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America CAR T-Cell Immunotherapy Market Size (2017-2028) 6.2 North America CAR T-Cell Immunotherapy Market Size by Type 6.2.1 North America CAR T-Cell Immunotherapy Market Size by Type (2017-2022) 6.2.2 North America CAR T-Cell Immunotherapy Market Size by Type (2023-2028) 6.2.3 North America CAR T-Cell Immunotherapy Market Share by Type (2017-2028) 6.3 North America CAR T-Cell Immunotherapy Market Size by Application 6.3.1 North America CAR T-Cell Immunotherapy Market Size by Application (2017-2022) 6.3.2 North America CAR T-Cell Immunotherapy Market Size by Application (2023-2028) 6.3.3 North America CAR T-Cell Immunotherapy Market Share by Application (2017-2028) 6.4 North America CAR T-Cell Immunotherapy Market Size by Country 6.4.1 North America CAR T-Cell Immunotherapy Market Size by Country (2017-2022) 6.4.2 North America CAR T-Cell Immunotherapy Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe CAR T-Cell Immunotherapy Market Size (2017-2028) 7.2 Europe CAR T-Cell Immunotherapy Market Size by Type 7.2.1 Europe CAR T-Cell Immunotherapy Market Size by Type (2017-2022) 7.2.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2023-2028) 7.2.3 Europe CAR T-Cell Immunotherapy Market Share by Type (2017-2028) 7.3 Europe CAR T-Cell Immunotherapy Market Size by Application 7.3.1 Europe CAR T-Cell Immunotherapy Market Size by Application (2017-2022) 7.3.2 Europe CAR T-Cell Immunotherapy Market Size by Application (2023-2028) 7.3.3 Europe CAR T-Cell Immunotherapy Market Share by Application (2017-2028) 7.4 Europe CAR T-Cell Immunotherapy Market Size by Country 7.4.1 Europe CAR T-Cell Immunotherapy Market Size by Country (2017-2022) 7.4.2 Europe CAR T-Cell Immunotherapy Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size (2017-2028) 8.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type 8.2.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2017-2022) 8.2.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2023-2028) 8.2.3 Asia-Pacific CAR T-Cell Immunotherapy Market Share by Type (2017-2028) 8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application 8.3.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2017-2022) 8.3.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2023-2028) 8.3.3 Asia-Pacific CAR T-Cell Immunotherapy Market Share by Application (2017-2028) 8.4 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region 8.4.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2017-2022) 8.4.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America CAR T-Cell Immunotherapy Market Size (2017-2028) 9.2 Latin America CAR T-Cell Immunotherapy Market Size by Type 9.2.1 Latin America CAR T-Cell Immunotherapy Market Size by Type (2017-2022) 9.2.2 Latin America CAR T-Cell Immunotherapy Market Size by Type (2023-2028) 9.2.3 Latin America CAR T-Cell Immunotherapy Market Share by Type (2017-2028) 9.3 Latin America CAR T-Cell Immunotherapy Market Size by Application 9.3.1 Latin America CAR T-Cell Immunotherapy Market Size by Application (2017-2022) 9.3.2 Latin America CAR T-Cell Immunotherapy Market Size by Application (2023-2028) 9.3.3 Latin America CAR T-Cell Immunotherapy Market Share by Application (2017-2028) 9.4 Latin America CAR T-Cell Immunotherapy Market Size by Country 9.4.1 Latin America CAR T-Cell Immunotherapy Market Size by Country (2017-2022) 9.4.2 Latin America CAR T-Cell Immunotherapy Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size (2017-2028) 10.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type 10.2.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2017-2022) 10.2.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2023-2028) 10.2.3 Middle East & Africa CAR T-Cell Immunotherapy Market Share by Type (2017-2028) 10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application 10.3.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2017-2022) 10.3.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2023-2028) 10.3.3 Middle East & Africa CAR T-Cell Immunotherapy Market Share by Application (2017-2028) 10.4 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country 10.4.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2017-2022) 10.4.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie 11.1.1 AbbVie Company Details 11.1.2 AbbVie Business Overview 11.1.3 AbbVie CAR T-Cell Immunotherapy Introduction 11.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.1.5 AbbVie Recent Developments 11.2 Celgene 11.2.1 Celgene Company Details 11.2.2 Celgene Business Overview 11.2.3 Celgene CAR T-Cell Immunotherapy Introduction 11.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.2.5 Celgene Recent Developments 11.3 Kite Pharma 11.3.1 Kite Pharma Company Details 11.3.2 Kite Pharma Business Overview 11.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction 11.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.3.5 Kite Pharma Recent Developments 11.4 Oxford BioMedica 11.4.1 Oxford BioMedica Company Details 11.4.2 Oxford BioMedica Business Overview 11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction 11.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.4.5 Oxford BioMedica Recent Developments 11.5 Novartis 11.5.1 Novartis Company Details 11.5.2 Novartis Business Overview 11.5.3 Novartis CAR T-Cell Immunotherapy Introduction 11.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.5.5 Novartis Recent Developments 11.6 Gilead 11.6.1 Gilead Company Details 11.6.2 Gilead Business Overview 11.6.3 Gilead CAR T-Cell Immunotherapy Introduction 11.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.6.5 Gilead Recent Developments 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Pfizer Business Overview 11.7.3 Pfizer CAR T-Cell Immunotherapy Introduction 11.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.7.5 Pfizer Recent Developments 11.8 Cellectis 11.8.1 Cellectis Company Details 11.8.2 Cellectis Business Overview 11.8.3 Cellectis CAR T-Cell Immunotherapy Introduction 11.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.8.5 Cellectis Recent Developments 11.9 Bellicum 11.9.1 Bellicum Company Details 11.9.2 Bellicum Business Overview 11.9.3 Bellicum CAR T-Cell Immunotherapy Introduction 11.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.9.5 Bellicum Recent Developments 11.10 Mustang Bio 11.10.1 Mustang Bio Company Details 11.10.2 Mustang Bio Business Overview 11.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction 11.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.10.5 Mustang Bio Recent Developments 11.11 CARsgen Therapeutics 11.11.1 CARsgen Therapeutics Company Details 11.11.2 CARsgen Therapeutics Business Overview 11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction 11.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.11.5 CARsgen Therapeutics Recent Developments 11.12 Xyphos 11.12.1 Xyphos Company Details 11.12.2 Xyphos Business Overview 11.12.3 Xyphos CAR T-Cell Immunotherapy Introduction 11.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.12.5 Xyphos Recent Developments 11.13 Minerva Biotechnologies 11.13.1 Minerva Biotechnologies Company Details 11.13.2 Minerva Biotechnologies Business Overview 11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction 11.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.13.5 Minerva Biotechnologies Recent Developments 11.14 Adaptimmune 11.14.1 Adaptimmune Company Details 11.14.2 Adaptimmune Business Overview 11.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction 11.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.14.5 Adaptimmune Recent Developments 11.15 Ziopharm Oncology 11.15.1 Ziopharm Oncology Company Details 11.15.2 Ziopharm Oncology Business Overview 11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction 11.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.15.5 Ziopharm Oncology Recent Developments 11.16 Aurora Biopharma 11.16.1 Aurora Biopharma Company Details 11.16.2 Aurora Biopharma Business Overview 11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction 11.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.16.5 Aurora Biopharma Recent Developments 11.17 Creative Biolabs 11.17.1 Creative Biolabs Company Details 11.17.2 Creative Biolabs Business Overview 11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction 11.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2017-2022) 11.17.5 Creative Biolabs Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Monotherapy Table 3. Key Players of Combination Therapy Table 4. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global CAR T-Cell Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million) Table 7. Global CAR T-Cell Immunotherapy Market Share by Region (2017-2022) Table 8. Global CAR T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global CAR T-Cell Immunotherapy Market Share by Region (2023-2028) Table 10. CAR T-Cell Immunotherapy Market Trends Table 11. CAR T-Cell Immunotherapy Market Drivers Table 12. CAR T-Cell Immunotherapy Market Challenges Table 13. CAR T-Cell Immunotherapy Market Restraints Table 14. Global CAR T-Cell Immunotherapy Revenue by Players (2017-2022) & (US$ Million) Table 15. Global CAR T-Cell Immunotherapy Revenue Share by Players (2017-2022) Table 16. Global Top CAR T-Cell Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2021) Table 17. Ranking of Global Top CAR T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by CAR T-Cell Immunotherapy Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players CAR T-Cell Immunotherapy Product Solution and Service Table 21. Date of Enter into CAR T-Cell Immunotherapy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 24. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2017-2022) Table 25. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2023-2028) Table 27. Global CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 28. Global CAR T-Cell Immunotherapy Revenue Share by Application (2017-2022) Table 29. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global CAR T-Cell Immunotherapy Revenue Share by Application (2023-2028) Table 31. North America CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 32. North America CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 33. North America CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 34. North America CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 35. North America CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 36. North America CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific CAR T-Cell Immunotherapy Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 61. AbbVie Company Details Table 62. AbbVie Business Overview Table 63. AbbVie CAR T-Cell Immunotherapy Product Table 64. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 65. AbbVie Recent Developments Table 66. Celgene Company Details Table 67. Celgene Business Overview Table 68. Celgene CAR T-Cell Immunotherapy Product Table 69. Celgene Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 70. Celgene Recent Developments Table 71. Kite Pharma Company Details Table 72. Kite Pharma Business Overview Table 73. Kite Pharma CAR T-Cell Immunotherapy Product Table 74. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 75. Kite Pharma Recent Developments Table 76. Oxford BioMedica Company Details Table 77. Oxford BioMedica Business Overview Table 78. Oxford BioMedica CAR T-Cell Immunotherapy Product Table 79. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 80. Oxford BioMedica Recent Developments Table 81. Novartis Company Details Table 82. Novartis Business Overview Table 83. Novartis CAR T-Cell Immunotherapy Product Table 84. Novartis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 85. Novartis Recent Developments Table 86. Gilead Company Details Table 87. Gilead Business Overview Table 88. Gilead CAR T-Cell Immunotherapy Product Table 89. Gilead Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 90. Gilead Recent Developments Table 91. Pfizer Company Details Table 92. Pfizer Business Overview Table 93. Pfizer CAR T-Cell Immunotherapy Product Table 94. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 95. Pfizer Recent Developments Table 96. Cellectis Company Details Table 97. Cellectis Business Overview Table 98. Cellectis CAR T-Cell Immunotherapy Product Table 99. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 100. Cellectis Recent Developments Table 101. Bellicum Company Details Table 102. Bellicum Business Overview Table 103. Bellicum CAR T-Cell Immunotherapy Product Table 104. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 105. Bellicum Recent Developments Table 106. Mustang Bio Company Details Table 107. Mustang Bio Business Overview Table 108. Mustang Bio CAR T-Cell Immunotherapy Product Table 109. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 110. Mustang Bio Recent Developments Table 111. CARsgen Therapeutics Company Details Table 112. CARsgen Therapeutics Business Overview Table 113. CARsgen Therapeutics CAR T-Cell Immunotherapy Product Table 114. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 115. CARsgen Therapeutics Recent Developments Table 116. Xyphos Company Details Table 117. Xyphos Business Overview Table 118. Xyphos CAR T-Cell Immunotherapy Product Table 119. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 120. Xyphos Recent Developments Table 121. Minerva Biotechnologies Company Details Table 122. Minerva Biotechnologies Business Overview Table 123. Minerva Biotechnologies CAR T-Cell Immunotherapy Product Table 124. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 125. Minerva Biotechnologies Recent Developments Table 126. Adaptimmune Company Details Table 127. Adaptimmune Business Overview Table 128. Adaptimmune CAR T-Cell Immunotherapy Product Table 129. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 130. Adaptimmune Recent Developments Table 131. Ziopharm Oncology Company Details Table 132. Ziopharm Oncology Business Overview Table 133. Ziopharm Oncology CAR T-Cell Immunotherapy Product Table 134. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 135. Ziopharm Oncology Recent Developments Table 136. Aurora Biopharma Company Details Table 137. Aurora Biopharma Business Overview Table 138. Aurora Biopharma CAR T-Cell Immunotherapy Product Table 139. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 140. Aurora Biopharma Recent Developments Table 141. Creative Biolabs Company Details Table 142. Creative Biolabs Business Overview Table 143. Creative Biolabs CAR T-Cell Immunotherapy Product Table 144. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 145. Creative Biolabs Recent Developments Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Global CAR T-Cell Immunotherapy Market Share by Type: 2021 VS 2028 Figure 2. Monotherapy Features Figure 3. Combination Therapy Features Figure 4. Global CAR T-Cell Immunotherapy Market Share by Application: 2021 VS 2028 Figure 5. Hematologic Malignancies Case Studies Figure 6. Solid Malignancies Case Studies Figure 7. CAR T-Cell Immunotherapy Report Years Considered Figure 8. Global CAR T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global CAR T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global CAR T-Cell Immunotherapy Market Share by Region: 2021 VS 2028 Figure 11. Global CAR T-Cell Immunotherapy Market Share by Players in 2021 Figure 12. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2021) Figure 13. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2021 Figure 14. North America CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 16. North America CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 17. North America CAR T-Cell Immunotherapy Market Size Share by Country (2017-2028) Figure 18. United States CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 22. Europe CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 23. Europe CAR T-Cell Immunotherapy Market Size Share by Country (2017-2028) Figure 24. Germany CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific CAR T-Cell Immunotherapy Market Size Share by Region (2017-2028) Figure 34. China CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 42. Latin America CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 43. Latin America CAR T-Cell Immunotherapy Market Size Share by Country (2017-2028) Figure 44. Mexico CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa CAR T-Cell Immunotherapy Market Size Share by Country (2017-2028) Figure 50. Turkey CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 54. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 55. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 56. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 57. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 58. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 59. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 60. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 61. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 62. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 63. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 64. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 65. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 66. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 67. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 68. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 69. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.